April 20, 2005, 12:59 PM
Join Date: October 6, 1998
Location: South Florida
March 2004: SWAT Briefing Room, by Denny Hansen:
In the December issue we ran a story on a product called QuikClot™. The product is a hemostatic agent that causes blood to clot upon contact. It has come to our attention that the product did not work “as advertised” on several severe wounds in Iraq.
Simply pouring QuikClot onto a severe wound, such as a spurting artery, may only be effective if applied in a buddy system, with one person applying QuikClot and another applying direct pressure. Also, when QuikClot is poured into a hemorrhaging wound a reaction begins heating the blood to temperatures from 194-212 degrees Fahrenheit.
It is these high temperatures which help make the blood clot—it also heats local skin, muscle and nerve tissue to boiling temperatures.It is our understanding that until the product undergoes further testing, its use has been prohibited by USSOCOM and USSOCOM personnel. We advise any S.W.A.T. readers to look into the use of QuikClot before applying it.
May 2004: Letters to the Editor:
Dear Mr. Hansen,
We at Z-Medica would like to respond to “Briefing Room” in the March 2004 issue, discussing our hemostatic product, QuikClot®. The editorial, as written, appears to reflect dated and incorrect information that has subsequently been refuted by field experience and peer-reviewed scientific testing. QuikClot, when used as directed for the control of moderate to severe hemorrhage, has been shown to be extremely effective and safe in both military and civilian settings. QuikClot has been credited with making the difference between life and death in numerous reports from Iraq, even after all other means had failed.
We would like to invite the attention of your readers to the following clarifications:
1) The reference SOCOM directive was issued over one year ago, quickly followed by a directive from the Secretary of the Army declaring QuikClot safe and effective and authorizing use by US Army personnel.
2) The SOCOM directive incorrectly stated that the temperature increase caused by QuikClot was up to 100 degrees C, causing clotting. QuikClot begins clotting not by heat production, but by removing water from blood and creating a concentration of clotting factors in the wound. No temperature greater than 150 degrees F., and that only with inappropriate/off-label use, has ever been recorded with QuikClot.
3) In over 200 confirmed uses, there has never been an incident of burns when the package directions were followed.
4) The United States Marine Corps has made QuikClot a standard issue item. The Army and other services have purchased large quantities.
5) The complaints of QuikClot not working properly (fewer than five cases, most by the same user) have been attributed to inadequate training in its appropriate use.
6) The Office of Naval Research, and Uniformed Services University have done in-vitro and in-vivo studies. These found QuikClot safely and effectively stopped combined arterial/venous bleeding.
7) At a presentation given at the 2003 Special Operations Medical Conference, the director of OEMS, also the chief FBI medical advisor, recommended QuikClot as the best current solution in the field environment.
Manager, Product Development
Thank you for keeping us informed and bringing us up to date on QuikClot. Your efforts are appreciated, and I now carry QuikClot both in my vehicle and with my training gear.
Sounds to me like you need to recheck to see if your guys have the latest info.